Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 5,405,000 | 5,585,000 | 5,699,000 | 5,603,000 | 6,115,000 |
| Cost of Goods | 894,000 | 1,160,000 | 900,000 | 1,062,000 | 1,004,000 |
| Gross Profit | 4,511,000 | 4,425,000 | 4,799,000 | 4,541,000 | 5,111,000 |
| Operating Expenses | 3,594,000 | 1,892,000 | 3,771,000 | 4,238,000 | 4,073,000 |
| Operating Income | 917,000 | 2,533,000 | 1,028,000 | 303,000 | 1,038,000 |
| Interest Expense | 340,000 | 362,000 | 355,000 | 342,000 | 325,000 |
| Other Income | 5,000 | 12,000 | 3,000 | 9,000 | 10,000 |
| Pre-tax Income | 582,000 | 2,183,000 | 676,000 | -30,000 | 723,000 |
| Income Tax | 70,000 | 366,000 | -319,000 | 1,000 | 98,000 |
| Net Income Continuous | 512,000 | 1,817,000 | 995,000 | -31,000 | 625,000 |
| Minority Interests | -25,000 | -25,000 | -19,000 | -28,000 | -21,000 |
| Net Income | $537,000 | $1,842,000 | $1,014,000 | $-3,000 | $646,000 |
| EPS Basic Total Ops | 0.21 | 0.73 | 0.40 | 0.00 | 0.26 |
| EPS Basic Continuous Ops | 0.20 | 0.72 | 0.39 | -0.01 | 0.25 |
| EPS Diluted Total Ops | 0.21 | 0.73 | 0.40 | 0.00 | 0.26 |
| EPS Diluted Continuous Ops | 0.20 | 0.72 | 0.39 | -0.01 | 0.25 |
| EBITDA(a) | $1,575,000 | $3,123,000 | $1,639,000 | $890,000 | $1,607,000 |